Daniel Junius
Net worth: 2 M $ as of 2026-06-29
Net worth: 2 M $ as of 2026-06-29
Daniel M.
Junius currently serves as Independent Director at IDEXX Laboratories, Inc. since 2014, Treasurer & Director at Biotechnology Innovation Organization since 2014, and Chief Financial Officer at Deluxepinpoint Co. Formerly, Mr. Junius was Director at ImmunoGen, Inc. from 2016 to 2018, Director at Vitae Pharmaceuticals LLC in 2016, Independent Director at GlycoMimetics, Inc., Chief Financial Officer & Vice President at Nashua Corp.
from 1996 to 1998, and Chief Financial Officer & Executive Vice President at Deluxe Business Operations, Inc. from 2002 to 2004.
Education includes graduate studies at Kellogg School of Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-11 | 3,561 ( 0% ) | 2 M $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| IDEXX LABORATORIES, INC. | Director/Board Member | 2014-03-10 |
Deluxepinpoint Co.
Deluxepinpoint Co. Miscellaneous Commercial ServicesCommercial Services Provides office supplies and business services to customers | Director of Finance/CFO | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| IMMUNOGEN, INC. | Chief Executive Officer | 2016-05-15 |
| VITAE PHARMACEUTICALS INC | Director/Board Member | 2016-10-24 |
Deluxe Business Operations, Inc.
Deluxe Business Operations, Inc. Commercial Printing/FormsCommercial Services Used to design and produce printed products | Director of Finance/CFO | 2003-12-31 |
Nashua Corp.
Nashua Corp. Pulp & PaperProcess Industries Manufactures and markets coated paper products and toners for computers, copiers and facsimiles | Director of Finance/CFO | 1997-12-31 |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Nashua Corp.
Nashua Corp. Pulp & PaperProcess Industries Manufactures and markets coated paper products and toners for computers, copiers and facsimiles | Process Industries |
Deluxe Business Operations, Inc.
Deluxe Business Operations, Inc. Commercial Printing/FormsCommercial Services Used to design and produce printed products | Commercial Services |
IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. Medical SpecialtiesHealth Technology Develops animal diagnostic, software and imaging & water treatment systems | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Deluxepinpoint Co.
Deluxepinpoint Co. Miscellaneous Commercial ServicesCommercial Services Provides office supplies and business services to customers | Commercial Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions